Since both cell lines express TRAIL, it is likely that in TRAIL-R4-KD cells binding of tumor cell-derived TRAIL to TRAIL-R1/R2 results in the constitutively increased activity of ERK and AKT. The gene discussed is TNFSF10; the disease is neoplasm.